Analyst Price Targets — HYPR
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| March 22, 2024 6:17 am | Larry Biegelsen | Wells Fargo | $1.60 | $1.01 | StreetInsider | Hyperfine Inc. (HYPR) PT Lowered to $1.60 at Wells Fargo |
| August 11, 2022 10:19 am | Larry Biegelsen | Wells Fargo | $2.40 | $1.50 | TheFly | Hyperfine slides after lowering expectations, Wells Fargo downgrade |
Latest News for HYPR
GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine initiates the launch of the next-gen Swoop® system in Europe, beginning global expansion of its most advanced portable MRI technology. .
GUILFORD, Conn.--(BUSINESS WIRE)--Leading neurosurgeons will help guide the role of the Swoop® system in neurosurgical care, including workflow, product capabilities, and evidence.
[url="]Hyperfine, Inc.[/url] (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powere
GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine announces Swoop® system scan volume milestones at key hospitals and neurology clinics, demonstrating accelerating adoption across the US.
Hyperfine, Inc. (HYPR) Presents at Jefferies Global Healthcare Conference 2026 Prepared Remarks Transcript
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for HYPR.
U.S. House Trading
No House trades found for HYPR.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.